Introduction
Corynebacterium glutamicum is a soil actinobacterium that is used industrially for the production of amino acids and proteins (Hermann, 2003; Becker and Wittmann, 2012; Eggeling and Bott, 2015; Wendisch et al., 2016) .
Due to its excellent properties as a microbial cell factory and its close phylogenetic relationship to pathogenic bacteria such as Mycobacterium tuberculosis, Mycobacterium leprae or Corynebacterium diphtheriae, C. glutamicum has become an intensively studied model organism of the order Corynebacteriales, in particular with respect to metabolism and regulation (Eggeling and Bott, 2005; Burkovski, 2008; Yukawa and Inui, 2013; Burkovski, 2015) .
The universal second messenger 3 0 ,5 0 -cyclic adenosine monophosphate (cAMP) plays an important role in many bacteria (Botsford and Harman, 1992) . This holds also true for C. glutamicum, where cAMP is involved in the regulation of a large number of genes through the cAMP-dependent transcriptional regulator GlxR (Kim et al., 2004; Kohl and Tauch, 2009) . GlxR belongs to the CRP/FNR family of transcriptional regulators and shows similarity to the cAMP receptor protein CRP of Escherichia coli, which is necessary for the expression of numerous catabolic genes (Malan et al., 1984; Kolb et al., 1993; Tagami and Aiba, 1998; Busby and Ebright, 1999; G€ orke and St€ ulke, 2008) . GlxR of C. glutamicum (Cg0350) was initially identified as regulator of the glyoxylate cycle gene aceB (Kim et al., 2004) . Subsequent studies showed that GlxR is a global regulator that controls expression of numerous genes in C. glutamicum, thereby affecting a variety of cellular functions such as transport processes, central carbon metabolism, respiration, stress responses, or resuscitation (Letek et al., 2006; Bott, 2007; Jungwirth et al., 2008; Kohl et al., 2008; Bussmann et al., 2009; Kohl and Tauch, 2009; Toyoda et al., 2009; Park et al., 2010; Schr€ oder and Tauch, 2010; Toyoda et al., 2011; Jungwirth et al., 2013; Subhadra and Lee, 2013) . Mutants with deletions within glxR exhibited drastic growth defects (Toyoda et al., 2009; Park et al., 2010) , underlining the importance of GlxR in this organism. Recently, the crystal structures of apo-GlxR and holo-GlxR have been determined and revealed that the protein undergoes a distinctive conformational change upon cAMP binding leading to a dimer structure allowing specific DNA-binding (Townsend et al., 2014) . Furthermore, in a recent study the subtilisin-like serine protease SprA was reported to specifically interact with GlxR and purified SprA was shown to proteolytically degrade GlxR (Hong et al., 2014) . This degradation was inhibited in the presence of cAMP, indicating that cAMP binding to GlxR protects the protein from cleavage (Hong et al., 2014) .
The cellular cAMP level is controlled by the activity of cAMP synthesizing and degrading enzymes. To date, only one such enzyme has been identified in C. glutamicum, which is the adenylate cyclase encoded by cyaB (Cha et al., 2010) . CyaB (Cg0375) is a membrane-bound class III adenylate cyclase catalyzing the formation of cAMP and pyrophosphate from ATP. In contrast to the glxR gene, the cyaB gene could easily be deleted, suggesting the existence of another yet unknown adenylate cyclase in C. glutamicum (Cha et al., 2010) . Degradation of 3 0 ,5 0 -cAMP is usually mediated by cAMP phosphodiesterases (PDEs), which hydrolyze the 3 0 -phosphoester bond to form 5 0 -AMP. The known PDEs working on cAMP have been assigned to three classes (Richter, 2002) . The first class is found in higher eukaryotes and contains all human cAMP and cGMP PDEs (Conti and Beavo, 2007) . The second class covers PDEs of lower eukaryotes such as Saccharomyces cerevisiae (Ma et al., 1999) , Candida albicans (Hoyer et al., 1994) and Dictyostelium discoideum (Lacombe et al., 1986) as well as PDEs of bacteria such as Vibrio fischeri (Dunlap and Callahan, 1993; Callahan et al., 1995) or Myxococcus xanthus (Kimura et al., 2011) . All members of this class contain the conserved sequence motif HxHLDH (Richter, 2002) . The histidine and aspartate residues in this motif are involved in the coordination of metal ions which are bound in the catalytic centre of the protein (Tian et al., 2014) . The third class of PDEs has so far only been found in bacteria, such as E. coli (Imamura et al., 1996) , M. tuberculosis (Shenoy et al., 2005 (Shenoy et al., , 2007 , Pseudomonas aeruginosa (Fuchs et al., 2010) , M. xanthus (Kimura et al., 2006 (Kimura et al., , 2009 , or Serratia marcescens (Kalivoda et al., 2013) . The class III PDEs show similarity to purple acid phosphatases and harbour the conserved sequence motif D-(x) n -GD-(x) n -GNH[E/D]-(x) n -H-(x) n -GHXH. In general, all of the known cAMP PDEs depend on metal ions which differ between the classes and enzymes (Richter, 2002) . For the class II cAMP PDEs of S. cerevisiae and V. fischeri the bound metal ions are two zinc ions (Londesborough and Suoranta, 1983; Callahan et al., 1995) , while the class III PDE of M. tuberculosis contains iron and manganese ions (Shenoy et al., 2005) .
Although GlxR and its effector cAMP play such a prominent role in the regulation of metabolism in C. glutamicum (Schr€ oder and Tauch, 2010) , a detailed physiological understanding of this regulatory system is precluded by the lack of knowledge on how the intracellular cAMP concentration is controlled. In order to increase our understanding of the control of the cellular cAMP level, we searched for genes involved in cAMP degradation in C. glutamicum and identified cg2761. The function of the Cg2761 protein as cAMP-PDE was confirmed biochemically and by increased cellular cAMP levels in a cg2761 deletion mutant. This mutant showed severe growth defects on a variety of carbon sources, confirming the importance of the cAMP level for optimal metabolism and growth. Furthermore, cg2761 was found to be transcriptionally activated by GlxR, thus establishing a feedback loop that triggers cAMP degradation at high cAMP levels.
Results

Identification of cg2761 as putative cAMP-PDE encoding gene
In an effort to identify genes that might encode cAMPPDEs in the genome of C. glutamicum, a DELTA-BLAST (Boratyn et al., 2012) search was conducted using amino acid sequences of known class II and III cAMP-PDEs of other organisms as templates. Thereby, the protein encoded by cg2761 was identified as a putative candidate. It possessed only 15%-19% sequence identity to known class II cAMP-PDEs, such as S. cerevisiae PDE1 (16%), V. fischeri CpdP (15%), Yersinia pestis CpdP (putative PDE, 15%), M. xanthus PdeE (19%), D. discoideum PDE1 (15%) and C. albicans PDE1 (17%), but contained the sequence motif HxHTDH, which, except for one deviation, corresponds to the motif HxHLDH characteristic for class II cAMP-PDEs (Richter, 2002) . Cg2761 is predicted to comprise 255 amino acid residues with a calculated mass of 27,486 Da and a calculated pI of 4.70. In the following, the Cg2761 protein was named CpdA for cAMP phosphodiesterase A. Homologs of the CpdA protein were found to be present in many genera of Actinobacteria, including, for example, Mycobacterium, Rhodococcus, Nocardia, Arthrobacter, Saccharomonospora, Amycolatopsis, Micrococcus and Streptomyces, but none of these proteins has been characterized yet. An amino acid sequence alignment of Cg2761 with experimentally characterized representatives of class II cAMP-PDEs and homologs of other Actinobacteria is shown in Supporting Information Fig. S1 .
Biochemical characterization of CpdA as a cAMP-PDE
The putative cAMP-PDE activity of CpdA was first examined by overexpression in E. coli followed by growth on MacConkey agar plates supplemented with maltose as carbon source. cAMP-dependent utilization of maltose on these plates is indicated by a color change from red to pink caused by acidification of the The cAMP phosphodiesterase CpdA of C. glutamicum 535 medium (Sismeiro et al., 1998; Shuman and Silhavy, 2003) . The colonies of the negative control E. coli BTH2/pEKEx2, which is unable to synthesize cAMP due to the absence of the adenylate cyclase gene cya, remained pale, whereas the positive control E. coli DH5a/pEKEx2 formed colonies with an intense pink color (Fig. 1 ). Strains and plasmids used or constructed in this study are described in Table 1 and in the section 'Experimental Procedures'. Overexpression of cpdA in E. coli DH5a with plasmid pEKEx2-cpdA caused a strong reduction of growth accompanied by reduced pink staining. In contrast, growth of this strain on LB agar was comparable to that of the control strain E. coli DH5a/pEKEx2 (Fig. 1) . This result supported the assumption that the cpdA gene product might be a cAMP-PDE.
To prove the cAMP-PDE activity of the CpdA protein in vitro, a variant with an N-terminal decahistidine tag was overproduced in C. glutamicum MB001(DE3) carrying pMKEx1-cpdA and purified to apparent homogeneity. The activity of the purified protein was tested with a coupled enzyme assay in which 5 0 -AMP formation from cAMP is measured as oxidation of NADH (assay 1). By using different concentrations of CpdA protein in the coupled enzyme assay it was ensured that the determined cAMP degradation rate is only limited by the amount of CpdA. CpdA was able to cleave 3 0 ,5 0 -cAMP with a K app m value for cAMP of 2.5 6 0.3 mM and a V app max of 33.6 6 4.3 mmol min 21 mg 21 when measured at pH 7.5 and 308C ( Fig. 2A,B) . The turnover number of monomeric CpdA was calculated as 18.1 s
21
. In order to confirm these results, the kinetic parameters of CpdA were determined using the alternative assay 2, in which phosphate cleaved from a nucleotide monophosphate by alkaline phosphatase is detected (Kalivoda et al., 2013) . Using this second assay, K app m and V app max of CpdA were determined to be 1.12 6 0.06 mM and 23.1 6 3.8 mmol min 21 mg 21 (Fig. 2C,D) . The enzyme kinetics obtained with this second assay suggested the presence of negative cooperativity, which is probably caused by the inhibition of the helper enzyme alkaline phosphatase by the reaction product phosphate, as demonstrated earlier (Fernley and Walker, 1967) . The inhibition of the alkaline phosphatase presumably leads to the reduced V max determined with assay 2. The pH and temperature optima of CpdA, determined with the artificial substrate bis-(p-nitrophenyl) phosphate (assay 3), were at pH 6.5-7.0 and 658C-708C respectively. The purified CpdA was found to be in dimeric or tetrameric state as determined by size exclusion chromatography. An ICP-MS analysis revealed the presence of 2.80 6 0.13 zinc atoms per molecule of purified CpdA, which is consistent with the fact that related PDEs of V. fischeri and S. cerevisiae contain zinc as well (Callahan et al., 1995; Tian et al., 2014) .
It is known for other class II PDEs such as PdeE of M. xanthus or CpdP of V. fischeri (Callahan et al., 1995; Kimura et al., 2011) corresponding to a twofold increase compared with the wild-type level. Upon complementation of the DcpdA mutant with pEKEx2-cpdA, the cAMP level was reversed to a level of 14.8 6 6.5 pmol (mg protein)
, confirming the functional expression of cpdA by pEKEx2-cpdA and demonstrating cpdA overexpression in this strain. These results indicate that CpdA is present and active in C. glutamicum and plays a key role in controlling the cellular cAMP concentration.
Influence of cpdA deletion and overexpression on growth
As shown in Fig. 3 , the DcpdA mutant showed considerable growth defects on all carbon sources tested. In glucose and gluconate minimal media, the growth rate was reduced by 45%. When cultivated in minimal medium with acetate or citrate, the DcpdA mutant showed a long lag phase and a reduction of the growth rate by 47% and 62% respectively. No differences between wild type and (Hanahan, 1983) E. coli BTH2 F 2 cya-99 araD139 rpsL1 hsdR2 mcrA1 mcrB1, adenylate cyclase deficient E. coli strain (Hantke et al., 2011) C. glutamicum ATCC 13032
Biotin-auxotrophic wild type (WT) (Kinoshita et al., 1957) C. glutamicum MB001(DE3) ATCC 13032 derivative with deletion of prophages CGP1, CGP2 and CGP3 and chromosomally integrated genes for E. coli LacI and T7-RNA polymerase (Kortmann et al., 2015) C. The cAMP phosphodiesterase CpdA of C. glutamicum 537 the DcpdA mutant were observed for the final optical densities when cultivated on glucose, gluconate, acetate, or citrate. However, during growth on 200 mM ethanol supplemented with 5 mM glucose the final backscatter value of the DcpdA mutant was reduced by 70%-75% (Fig. 3E ). The growth kinetics of the DcpdA mutant suggests that its capability for ethanol utilization was almost completely lost. All growth defects of the DcpdA mutant described above were complemented by plasmid-based expression of cpdA using pEKEx2-cpdA, confirming that they are caused by the absence of the cAMPphosphodiesterase gene. In contrast to the severe phenotype of the DcpdA mutant, overexpression of cpdA in the wild type with pEKEx2-cpdA did not cause significant alterations in growth behavior (Fig. 3) . The ability to reverse the growth defect of the DcpdA mutant by plasmid-based cpdA expression allowed us to test the relevance of individual CpdA amino acid residues for protein function. Based on the sequence alignment shown in Supporting Information Fig. S1 and a structural model of CpdA (not shown), nine conserved residues mapping to the catalytic centre of CpdA were exchanged for alanine and the corresponding mutated pEKEx2-cpdA expression plasmids were tested for their ability to reverse the DcpdA growth defect on glucose. Full reversal was achieved with the CpdA variants carrying the amino acid exchanges H64A, H142A, E185A and H222A, whereas complementation was disturbed with the CpdA variants H59A, H61A, D63A, D165A and H200A (data not shown). These results suggest that H59, H61, D63, D165 and H200 are important for CpdA function.
Influence of cpdA deletion on global gene expression
The doubled cAMP concentration in cells of the DcpdA mutant is expected to influence the activity of the global (mM/(μmol min mg ))
[cNMP] (mM) Fig. 2 . Determination of kinetic parameters of the cAMP-PDE of CpdA using purified His-tagged protein and either assay 1 (panels A and B, coupled enzyme assay with adenylate kinase, pyruvate kinase and lactate dehydrogenase) or assay 2 (panels C and D, coupled enzyme assay with alkaline phosphatase). Both assays were performed at 308C in 100 mM MOPS buffer, pH 7.5. The reaction was started by addition of cAMP or cGMP. In assay 1, the decrease in absorbance of NADH was followed continuously at 340 nm. About 1 mmol of NADH oxidized corresponds to 0.5 mmol cAMP converted to AMP. In assay 2 samples were taken at several time points after start of the reaction and the released phosphate was measured. The values shown for K transcriptional regulator GlxR, whose activity is dependent on cAMP. We therefore compared global gene expression of the DcpdA mutant and the wild type with DNA microarrays using RNA isolated in the exponential growth phase of glucose-grown cells. As shown in Supporting Information Table S1 , 66 genes showed a 2-fold increased and 181 genes a 2-fold decreased mRNA level in the DcpdA mutant (mean values of three biological replicates, p-value 0.05). About 20 of the 66 upregulated genes and 62 of the 181 downregulated genes are known or predicted target genes of GlxR (indicated in Supporting Information Table S1 ). This ratio
Glucose Gluconate Acetate Citrate
Ethanol + Glucose Fig. 3 . Effect of cpdA deletion and overexpression on growth of C. glutamicum with different carbon sources. The strains were cultivated in minimal medium with 100 mM glucose (A), 100 mM sodium gluconate (B), 100 mM sodium acetate (C), 100 mM sodium citrate supplemented with 5 mM CaCl 2 (D), or 200 mM ethanol 1 5 mM glucose (E) as carbon source in the BioLector. About 250 mM IPTG was added to all cultures after 2 h to induce expression of cpdA from the tac promoter in pEKEx2-cpdA. Mean values and standard deviations of at least three biological replicates are shown.
The cAMP phosphodiesterase CpdA of C. glutamicum 539 Molecular Microbiology, 103, [534] [535] [536] [537] [538] [539] [540] [541] [542] [543] [544] [545] [546] [547] [548] [549] [550] [551] [552] between up-and downregulated genes is in agreement with previous data showing that the majority of target genes are repressed by GlxR (according to CoryneRegNet [Pauling et al., 2012] 78 out of 104 regulated operons are repressed by GlxR). Table 2 shows a selection of genes with altered expression in the DcpdA mutant disclosing that many genes of the phosphoenolpyruvate (PEP)-dependent phosphotransferase system Table S1 and data were deposited in the GEO database under series entry GSE81004. c. R, gene repressed by GlxR; A, gene activated by GlxR according to CoryneRegNet (Pauling et al., 2012) .
(PTS), glycolysis, the tricarboxylic acid cycle and anaplerosis showed reduced expression. Genes involved in gluconate catabolism (gntK), citrate uptake (citH, tctAB) and ethanol catabolism (adh, ald) were also downregulated. These changes correlated with the growth defects of the DcpdA mutant described above. Possible reasons for the observations that (i) about two thirds of the genes with altered expression in the DcpdA mutant have not been reported as GlxR targets and (ii) only 51 out of 193 experimentally supported GlxR target genes showed altered expression in the DcpdA mutant are presented in the discussion. Upon overexpression of cpdA in the wild type only 16 genes showed altered expression levels (Supporting Information Table S2 ). All of the eight up-regulated genes and four of the eight downregulated genes are known or predicted GlxR targets.
Influence of overexpression of selected genes on the growth of the DcpdA mutant
The transcriptome data of the DcpdA mutant revealed several down-regulated genes which might be responsible for the observed growth defects. The reduced growth rate on glucose might be caused by the fourfold lowered expression of the genes ptsG and ptsI encoding enzyme II of the glucose-specific PTS and of the general PTS component EI. Expression of ptsI-ptsG with plasmid pEKEx2-ptsI-ptsG almost completely abolished the growth defect of the DcpdA mutant on glucose (Fig. 4A) . Possible reasons for the reduced growth rates on the other carbon sources could also be deduced from the transcriptome data. Regarding the utilization of citrate, the genes for both citrate uptake systems (Brocker et al., 2009) , tctCBA and citH are repressed by GlxR (Kohl and Tauch, 2009; Toyoda et al., 2011) and showed 2.5-to 3-fold reduced mRNA levels in the DcpdA mutant. Overexpression of citH with plasmid pEKEx2-citH led to nearly wild type-like growth with citrate as carbon source (Fig.  4D) . Thus, down-regulation of genes involved in glucose and citrate uptake was indeed responsible for the growth phenotypes.
In the case of gluconate, both gntP and gntK encoding gluconate permease and gluconate kinase are negatively regulated by GlxR (Letek et al., 2006) . Whereas the mRNA ratio of gntP could not be determined, transcription of gntK was 7-fold reduced in the DcpdA mutant. Plasmid-based overexpression of gntK and gntP with plasmid pEKEx2-gntK-gntP could partially abolish the growth defect of the DcpdA mutant on gluconate (Fig. 4B ). In the case of acetate, the genes responsible for the activation to acetyl phosphate and acetyl-CoA, ackA and pta (Reinscheid et al., 1999) , had 10-and 5-fold decreased expression levels in the DcpdA mutant, which could be responsible for the reduced growth rate on acetate. Plasmid-based overexpression of the pta-ackA operon with pEKEx2-pta-ackA could partially abolish the growth defects of the DcpdA mutant on acetate (Fig. 4C) . The incomplete reversal of the growth defects in the case of gluconate and acetate indicates that further bottlenecks in the catabolic pathways exist besides gntK-gntP and pta-ackA expression respectively. In the case of ethanol, neither overexpression of pta-ackA alone nor of adhA (encoding alcohol dehydrogenase) and ald (encoding acetaldehyde dehydrogenase) with plasmid pEKEx2-adhA-ald could improve growth (Fig. 4E) .
Evidence for transcriptional activation of cpdA by cAMP-GlxR Inspection of the promoter region of cpdA revealed a putative GlxR binding site (TGTGtnnTAnnTCtgA) centred at position 285 with respect to the transcriptional start site (Fig. 5A) , raising the question whether cpdA might be a target gene of GlxR that had not been detected in previous studies. Therefore, the regulation of cpdA expression by GlxR was tested with a system composed of two plasmids, pJC1-PcpdA-venus carrying the reporter gene venus under control of the cpdA promoter and pXMJ19-glxR allowing IPTG-inducible GlxR overproduction. Increased GlxR levels should have a positive or negative influence on reporter gene expression, depending on the role of GlxR for the cpdA promoter. The effect of glxR overexpression was examined in glucose minimal medium for the wild type (regular cAMP level) and the DcpdA mutant (twofold increased cAMP level).
In the wild type full induction of glxR expression (250 mM IPTG) led to an increase of Venus fluorescence by 41% immediately after entering the stationary phase compared with the uninduced culture and the control strain carrying the empty plasmid pXMJ19 instead of pXMJ19-glxR (Fig. 5B) . Growth was slightly impaired in the presence of 100-250 mM IPTG, but not at lower IPTG concentrations (Supporting Information Fig. S2A ). In contrast, overexpression of glxR in the DcpdA mutant led to strongly impaired growth already in the presence of 25 mM IPTG (Supporting Information Fig. S2C ) and Venus fluorescence reached a lower value compared with the uninduced control (Fig. 5C ). As elaborated in the discussion, high GlxR levels in combination with the increased cAMP level in the DcpdA mutant apparently disturb metabolic control due to unphysiological levels of DNA-binding-competent GlxR. Without IPTG induction, the DcpdA strains carrying the reporter plasmid and either pXMJ19-glxR or the empty vector pXMJ19
The cAMP phosphodiesterase CpdA of C. glutamicum 541 showed a 58% higher Venus fluorescence compared with the uninduced wild-type strain (Fig. 5B,C) , in line with transcriptional activation of cpdA expression due to an increased cAMP level in the DcpdA mutant.
In order to test whether the positive regulation of cpdA expression by GlxR depends on the identified putative GlxR binding site, it was mutated by exchange of the conserved GTG motif to CAC Ethanol + Glucose Fig. 4 . Complementation of the growth defects of the C. glutamicum DcpdA mutant by reversing the reduced expression levels of genes involved in uptake and catabolism of the carbon sources. The genes whose expression was enhanced were ptsI and ptsG in the case of glucose (100 mM, panel A), gntK-gntP in the case of sodium gluconate (100 mM, panel B), pta and ackA in the case of sodium acetate (100 mM, panel C), citH in the case of sodium citrate (50 mM supplemented with 5 mM CaCl 2 , panel D), and either adhA and ald or pta and ack in the case of ethanol (200 mM supplemented with 5 mM glucose, panel D). The strains were cultivated in the BioLector using CGXII minimal medium with the indicated carbon sources, 25 mg ml 21 kanamycin, and 250 mM IPTG to induce expression of the respective target genes from the tac promoter of the pEKEx2-derived plasmids. Mean values and standard deviations of at least three biological replicates are shown.
(TGTGtnnTAnnTCtgA >TCACtnnTAnnTCtgA) in plasmid pJC1-PcpdA mut -venus and the same experiment as described above was repeated with the mutated version of the cpdA promoter. This time, full induction of glxR expression in the wild type only led to an increase of fluorescence by 9% in comparison to the uninduced control (Fig. 5D) . Moreover, the fluorescence measured for the uninduced DcpdA strain with the mutated cpdA promoter construct was only slightly higher than for the wild type (Fig. 5E ). Taken together, these results suggest that cpdA expression is activated by GlxR and involves the predicted GlxR binding site.
Discussion
In this study we describe the identification and characterization of a cAMP phosphodiesterase in Fig. 5 . Promoter region of cpdA (A) and influence of glxR overexpression on the promoter activity of cpdA expression measured as transcriptional fusion with the reporter gene venus (B-E). In (A) the cpdA start codon is indicated with orange letters, the transcriptional start site, which is identical with the first base of the start codon, is boxed and the 235 and 210 regions taken from (Pfeifer-Sancar et al., 2013) are indicated with green boxes. The putative GlxR binding site located at 285 bp relative to the transcriptional start is highlighted in purple and the mutated binding site is indicated above. Panels B-E show the fluorescence of the wild type and the DcpdA mutant transformed with plasmids pJC1-PcpdA-venus and pXMJ19-glxR. Control strains were transformed with the empty pXMJ19 plasmid instead of pXMJ19-glxR. The experiment was conducted both with the native version of the cpdA promoter (pJC1-PcpdA-venus, panels B and C) and after mutation of the putative GlxR binding site (pJC1-PcpdA mut -venus, panels D and E). The strains were cultivated in CGXII medium with 100 mM glucose in the BioLector. Expression of glxR was induced by addition of the indicated IPTG concentrations at time zero. The corresponding growth curves are shown as Supporting Information Fig. S2 .
The cAMP phosphodiesterase CpdA of C. glutamicum 543 values determined for purified CpdA Cg for 3 0 ,5 0 -cAMP were 1.2 and 2.5 mM depending on the assay used. These values are considerably higher compared with several other class II PDEs, such as S. cerevisiae PDE1 (110 mM) (Tian et al., 2014) , CpdP of V. fischeri (73 mM) (Callahan et al., 1995) or CpdE of Myxococcus xanthus (12 mM) (Kimura et al., 2011) . However, for a phosphodiesterase of Arthrobacter sp. CGMCC 3584, K m values of 6.82 mM for cAMP and 12.82 mM for cGMP were reported, which are even higher than those of C. glutamicum CpdA (Zheng et al., 2013) . The maximal activity measured for CpdA Cg (23.1-33.6 mmol min 21 mg
21
) was much lower than the one reported for CpdP of V. fischeri 3.7 mmol min 21 mg 21 (Callahan et al., 1995) , but much higher than that of M. xanthus CpdE (68 nmol min 21 mg 21 at 50 mM cAMP) (Kimura et al., 2011) . Thus, type II cAMP-PDEs can apparently have a broad range of K m and V max values. The temperature optimum determined for purified CpdA Cg of 658C-708C was quite high compared with the growth optimum of C. glutamicum (308C). However, a comparable behavior was also reported for CpdP of V. fischeri (Callahan et al., 1995) and might be due to a high protein stability conferred by the tightly bound metal ions. Furthermore, also other enzymes of C. glutamicum, such as aconitase (Baumgart and Bott, 2011) , were found to have temperature optima far above the optimal growth temperature.
Besides cAMP, CpdA Cg also catalyzed the hydrolysis of 3 0 ,5 0 -cGMP to GMP with a comparable K m value and somewhat lower V max compared with cAMP. In contrast, CpdA Cg did not react with AMP representing a phosphomonoester. Broadened substrate specificity has also been described for CpdP of V. fischeri which degrades not only cAMP but also several cyclic nucleotides as well as cyclic deoxynucleotides (Dunlap and Callahan, 1993; Callahan et al., 1995) . The phosphodiesterase PdeE of M. xanthus can degrade both cyclic nucleotides and phosphomonoesters such as AMP, although with lower activity (Kimura et al., 2011) . The PDE1 enzyme of S. cerevisiae also accepts both cAMP and cGMP as substrates (Tian et al., 2014) . It is not clear yet whether the ability of CpdA Cg to cleave cGMP is physiologically relevant or just represents substrate promiscuity, as at present nothing is known about cGMP in C. glutamicum. Knowledge about cGMP signalling in bacteria is in general scarce. A guanylyl cyclase encoded by cya2 was identified in Synechocystis PCC 6803 and deletion of cya2 caused a reduction of the cGMP level, but not of the cAMP level (Ochoa De Alda et al., 2000; Rauch et al., 2008) . Its physiological role is unclear. In Rhodospirillum centenum, deletion of the guanylyl cyclase gene resulted in the failure to synthesize cGMP and in a defective cyst formation, which could be reversed by exogenous addition of cGMP (Gomelsky, 2011; Marden et al., 2011) . Further studies are required to elucidate if cGMP plays a role in C. glutamicum and if CpdA Cg is relevant in that context.
The reports on the cAMP concentrations in C. glutamicum wild type differ considerably with values for glucose minimal medium varying between 10-30 pmol (mg protein) 21 (this work and (Polen et al., 2007) ) and 450 pmol (mg protein) 21 (Cha et al., 2010) . Assuming that protein makes up 50% of the cell dry weight and based on a cytoplasmic volume of 1.7 ml (mg dry weight)
(Kr€ amer et al., 1990), the reported cAMP concentrations correspond to cytoplasmic concentrations between 3 and 140 mM. These numbers are in the range of the K d values of 17 mM and 130 mM determined for cAMP binding to homodimeric GlxR (Townsend et al., 2014 The increased cAMP concentration in the DcpdA mutant should increase the activity of GlxR, as the fraction of GlxR with bound cAMP will presumably be increased, leading to stronger repression of the repressed genes and stronger activation of the activated genes. About 181 genes showed a 2-fold decreased mRNA level and 66 genes a 2-fold increased mRNA level in the DcpdA mutant compared with the wild type (Supporting Information Table S1 ). About one third of these genes are known GlxR targets, whereas the others (166) have not been reported to be targets of GlxR. This observation may be caused (i) by the assumption that the currently known GlxR regulon is incomplete, as demonstrated by the identification of cpdA as novel GlxR target, (ii) by the influence of the different growth rates of mutant and wild type on gene expression and (iii) by the fact that the GlxR regulon includes at least 25 genes for other transcriptional regulators (Kohl et al., 2008; Schr€ oder and Tauch, 2010; Toyoda and Inui, 2016) , including the master regulators RamA (Cramer et al., 2006) and RamB (Gerstmeir et al., 2004) . RamB and SugR (Engels and Wendisch, 2007) show increased mRNA levels in the DcpdA mutant. Complex regulatory interactions exist between GlxR, RamA, RamB and SugR (Subhadra et al., 2015; Toyoda and Inui, 2016) . Based on these facts, increased activity of GlxR in the DcpdA mutant due to an increased cAMP level is expected to influence expression not only of direct GlxR target genes, but also of genes controlled by regulators belonging to the GlxR regulon. Depending on the number and identity of the regulators involved in expression control of a certain gene, it can be difficult to predict the influence caused by an increased cAMP level.
The growth studies with the cpdA deletion strain revealed that CpdA plays an important role for the metabolism of C. glutamicum, as significantly reduced growth rates were observed for all carbon sources tested (Fig. 3) . Figure 6 shows a metabolic map highlighting known GlxR targets involved in the utilization of glucose, gluconate, citrate, acetate and ethanol. We assumed that reduced expression of genes coding for uptake systems or catabolic enzymes of these carbon sources could be responsible for the growth defects. In fact we were able to show that the growth defects on glucose and citrate could be abolished by plasmid-based expression of ptsIptsG and citH respectively. In the case of gluconate and acetate, partial restoration of wild type-like growth could be achieved by expression of gntK-gntP and pta-ackA respectively. The failure to fully abolish the growth defect on gluconate and acetate indicates that further enzyme activities are limiting in the DcpdA mutant, such as isocitrate lyase and malate synthase, whose genes aceA and aceB also showed 5-and 1.8-fold reduced expression.
The strongest growth defect of the DcpdA mutant was observed with ethanol as carbon source. The ethanol medium was supplemented with a small amount of glucose (5 mM) to facilitate induction of the genes adhA and ald for alcohol dehydrogenase (Arndt and Eikmanns, 2007 ) and acetaldehyde dehydrogenase (Auchter et al., 2009) . The latter enzyme oxidizes acetaldehyde to acetate. Both adhA and ald are strongly repressed by GlxR (Subhadra and Lee, 2013) . When cultivated on a mixture of glucose and ethanol, the C. glutamicum wild type shows one of the rare examples of diauxic growth (Arndt et al., 2008) . Although the mRNA ratios for adhA and ald were reduced in the same range as, for example, for ackA and pta, the DcpdA mutant showed almost no growth in the second growth phase with ethanol. This phenotype could not be compensated even partially by overexpression of adhA and ald or of the pta-ackA operon. As many genes essential for ethanol utilization showed downregulation in DcpdA, maybe all of them need to be overexpressed to allow growth. It is interesting to note that the strain overexpressing cpdA, which results in a lowered cAMP level, showed a better growth on ethanol than the wild type (Fig. 4E) , supporting the crucial role of cAMP in ethanol catabolism. A possible explanation for this effect could be the increased expression of ald in this strain (Supporting Information Table S2 ), which might accelerate ethanol metabolism. Another point that could be relevant for the strong growth defect on ethanol might be the toxic properties of this compound by altering membrane properties and provoking membrane leakage (Ingram, 1990) . Considering the extensive effects that changes in the cAMP concentration presumably have on numerous aspects of cellular processes, the DcpdA mutant might be especially sensitive to the harmful effects of ethanol.
Our reporter gene studies revealed that cpdA itself is transcriptionally activated by GlxR in a cAMPdependent manner, resulting in a feedback loop (Fig.  7) : an increase of the cAMP concentration raises the levels of the cAMP-GlxR complex and thus increases GlxR activity, including activation of cpdA expression. Raised CpdA levels result in an increased rate of cAMP degradation and thus a lowering of the cAMP level, if the cAMP-synthesis rate is not increased at the same time. In this way, CpdA can terminate the effect of an increased cAMP level. This regulatory feedback loop is further supported by DNA microarray experiments showing that the cpdA mRNA level was reduced threefold in a C. glutamicum DcyaB mutant compared with the wild type when cultivated on glucose. Reduction was even 8-fold when the same strains were cultivated on glucose plus acetate (unpublished data). As deletion of the adenylate cyclase gene cyaB causes lowered cAMP levels (Cha et al., 2010) , the reduced expression of cpdA in the cyaB mutant is in line with transcriptional activation of cpdA by GlxR. A similar mode of regulation, that is, transcriptional activation of cAMP-phosphodiesterase genes by a cAMPresponsive transcriptional regulator, was previously described only for two Gram-negative bacteria, Vibrio vulnificus, where the mutT-yqiB-cpdA-yqiA operon is activated by the cAMP-Crp complex (Kim et al., 2009) , and Pseudomonas aeruginosa, where cpdA expression is activated by the cAMP-Vfr complex (Fuchs et al., 2010) . Thus, our results for C. glutamicum are the first example for the occurrence of this feedback mechanism in Gram-positive bacteria.
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In conclusion, with the cAMP-PDE CpdA a third major player of the cAMP regulatory network in C. glutamicum besides GlxR and CyaB was identified. The analysis of a cpdA deletion mutant with respect to growth, global gene expression and cAMP levels revealed that CpdA plays a crucial role for cellular cAMP homeostasis and thereby for GlxR activity and the coordination of the metabolic network.
Experimental procedures
Strains, plasmids and growth media used in this study
The strains and plasmids used in this study are listed in Table 1 . C. glutamicum ATCC 13032 was used as wild type and cultivated at 308C in tryptone-yeast extract (2xTY) medium (Sambrook and Russell, 2001 ), brain heart infusion (BHI) medium (Difco Laboratories, Detroit, USA), or CGXII minimal medium containing 0.03 g l 21 protocatechuate as iron chelator (Frunzke et al., 2008) as indicated. E. coli was cultivated at 378C in lysogeny broth (LB) (Sambrook and Russell, 2001) . If appropriate, kanamycin (25 mg ml 21 for C. glutamicum, 50 mg ml 21 for E. coli) or chloramphenicol (10 mg ml
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) was added to the media.
Construction of plasmids and deletion mutants
Plasmid constructions were performed using standard cloning techniques as described (Sambrook and Russell, 2001) . Oligonucleotides were purchased from Eurofins MWG Operon (Ebersberg, Germany), enzymes from Thermo Scientific (Schwerte, Germany). The construction of plasmids pEKEx2-cpdA, pMKEx1-cpdA, pJC1-PcpdAvenus and pXMJ19-glxR was done following the same procedure: genes or promoter regions were amplified by PCR from C. glutamicum genomic DNA using the oligonucleotide pairs given in Supporting Information Table S3 . The PCR product and the respective plasmid were digested with the indicated restriction enzymes (Supporting Information Table  S3 ). Digested fragments were ligated using the Rapid DNA Ligation Kit (Roche Diagnostics, Mannheim, Germany) and transferred into E. coli DH5a cells by heat shock (Hanahan, 1983) . Recombinant plasmids were isolated from E. coli and checked by DNA sequencing (MWG Operon, Ebersberg, Germany). Construction of the plasmids pEKEx2-ptsIptsG, pEKEx2-gntK-gntP, pEKEx2-pta-ackA, pEKEx2-citH and pEKEx2-adhA-ald was achieved by Gibson assembly (Gibson et al., 2009) . PCR fragments covering the respective genes were generated using the oligonucleotides listed in Supporting Information Table S3 and included overlaps between the PCR fragments and the pEKEx2 backbone. pEKEx2 was digested with BamHI and SalI before plasmid and insert genes were fused in a single step isothermal Gibson reaction. The resulting products were used to transform E. coli and the plasmids were isolated and checked for correctness by sequencing. Subsequently they were transferred into C. glutamicum by electroporation (Tauch et al., 2002) . The pEKEx2 plasmids carrying the mutated cpdA variants were constructed from pEKEx2-cpdA by nucleotide exchange with the QuikChange Lightning Kit (Agilent Technologies, Waldbronn, Germany) according to the manufacturer's instructions. The primer pairs used for the nucleotide exchange are listed in Supporting Information Table S3 . The same method was used for the mutation of the GlxR binding site in plasmid pJC1-P cpdA -venus in order to construct pJC1-PcpdA mut -venus.
Plasmid pMKEx1 was constructed by integration of the expression cassette of pET-TEV (Bussmann et al., 2010) into plasmid pJC1, as described before for pMKEx2 (Kortmann et al., 2015) . In a first step, restriction sites for XbaI, SalI and BamHI were removed from the pJC1 backbone by digestion with BamHI and SalI followed by a Klenow fill-in and re-ligation of the plasmid. Then a 2.2 kb fragment carrying lacI, T7 promoter, ribosome binding site and T7 terminator sequence was amplified from pET-TEV with oligonucleotides pTEV1-for and pTEV1-expr-rev. pJC1 and the 2.2 kb PCR fragment were digested with PstI and ligated in a way that the lacI gene and kanamycin resistance gene on the backbone have the same orientation. The correct sequence of the plasmid was confirmed by DNA sequencing.
The construction of an in-frame C. glutamicum cpdA deletion mutant was performed by double homologous recombination as described previously (Niebisch and Bott, 2001 ) using plasmid pK19mobsacB-DcpdA (Sch€ afer et al., 1994) . The primer pairs del2761_Afw 1 Arv and del2761_Bfw 1 Brv were used to amplify regions of approximately 500 bp upstream and downstream of cpdA from genomic DNA. The resulting PCR products were fused by overlap extension PCR using primers del2761_Afw and del2761_Brv and cloned into pK19mobsacB via BamHI and PstI restriction sites. After transformation of C. glutamicum, cells were first selected for kanamycin resistance and subsequently for tolerance toward sucrose. Successful deletion of cpdA was confirmed by colony PCR with primers cg2761_deltest-fw and cg2761_deltest-rv. The resulting mutant DcpdA has a deletion of amino acids 2-226 of the 255 amino acids long CpdA protein, with additional 7 amino acids remaining in between due to the overlap that was used for cloning.
Parallel online measurement of growth and fluorescence
About 5 ml of 2xTY medium were inoculated with single colonies of the indicated C. glutamicum strains from BHI agar plates supplemented with the respective antibiotic. The precultures were incubated for 16-18 h at 308C with shaking at 170 rpm. Before inoculation of the main culture the cells were washed twice with saline [0.9% (wt/vol) NaCl]. The main culture was performed in 800 ml CGXII minimal medium inoculated to an optical density at 600 nm (OD 600 ) of 1. Carbon sources were added as indicated. Cells were cultivated for at least 24 h in 48-well FlowerplatesV R (m2p-labs, Baesweiler, Germany) in the BioLector The cAMP phosphodiesterase CpdA of C. glutamicum 547 system (m2p-labs, Baesweiler, Germany) at 308C, 80% humidity and shaking at 1200 rpm. Cell growth was monitored by measurement of backscattered light at 620 nm. Venus fluorescence was monitored in parallel (excitation at 510 nm, emission at 532 nm) if necessary.
Assay for cAMP-PDE activity in E. coli with MacConkey maltose agar Single colonies of the E. coli strains to be tested were inoculated from LB plates into 5 ml LB medium with kanamycin. After 16-18 h shaking at 378C these precultures were used to inoculate the main cultures (5 ml LB medium with kanamycin) to an OD 600 of 0.1. After shaking for 6 h at 378C and 170 rpm the cells were washed twice with saline, resuspended in saline and the OD 600 was adjusted to 0.5. This suspension and four consecutive 1:10 dilutions in saline were spotted in 4 ml drops on MacConkey agar (Difco TM , BD, Heidelberg, Germany) plates supplemented with 1% (wt/vol) maltose, 1 mM IPTG and 50 mg ml 21 kanamycin. Plates were incubated overnight at 378C and photographed the next morning. Three biological replicates were performed and yielded comparable results.
Overproduction and purification of CpdA C. glutamicum MB001(DE3) with the expression plasmid pMKEx1-cpdA was cultivated in 2xTY medium with kanamycin and cpdA expression was induced with 250 mM IPTG after 2 h incubation at 308C and 130 rpm. After cultivation for 7-8 h the cells were harvested by centrifugation (15 min at 4000g) and stored at 2208C. Cells of a 50 ml culture were washed once with 20 ml TNI5 buffer (20 mM Tris-HCl pH 7.9, 300 mM NaCl, 5 mM imidazole), resuspended in TNI5 buffer and disrupted by bead beating with a Precellys 24 device (Peqlab Biotechnologie, Erlangen, Germany). Cell debris and intact cells were sedimented by centrifugation for 15 min at 16,100g and 48C and the supernatant was transferred to a new reaction tube. The His 10 -tagged CpdA was purified to apparent homogeneity by Ni-chelate affinity chromatography on Ni-NTA Superflow resin (Qiagen, Hilden, Germany). The buffer of the CpdA-containing elution fraction was changed to PDE assay buffer (50 mM MOPS-KOH pH 7.5, 50 mM NaCl) using Amicon Ultra centrifugal filter units (10 kDa) (Merck Millipore, Darmstadt, Germany). Protein concentrations were determined with the bicinchoninic acid assay (Smith et al., 1985) . In order to determine the oligomeric state of CpdA size exclusion chromatography was performed. For this purpose protein purified from 100 ml cell culture by Ni-chelate affinity chromatography was pooled and concentrated to 500 ml using Amicon Ultra centrifugal filter units (10 kDa). The gel filtration was performed on a Superdex 200 increase 10/ 300 GL column (GE Healthcare, Munich, Germany) with gel filtration buffer (20 mM Tris-HCl pH 7.5, 50 mM NaCl) at a flow rate of 0.5 ml min
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. The protein containing fractions were then pooled again and concentrated to 0.75 ml using Amicon Ultra centrifugal filter units. A sample of the protein was used to determine the amount of bound metal ions after dilution with 3% (vol/vol) HNO 3 via sector ICP-MS analysis.
Phosphodiesterase assays
The PDE activities of CpdA were measured with three different assays depending on the reaction to be analyzed. Assay 1. For the determination of K m and V max values for the cAMP-PDE activity of CpdA, a coupled enzyme assay was used with adenylate kinase (myokinase), pyruvate kinase and L-lactate dehydrogenase. AMP, resulting from cleavage of cAMP by CpdA, and ATP are converted to two molecules ADP by adenylate kinase. ADP and PEP are converted to pyruvate and ATP by pyruvate kinase, thereby regenerating ATP. Finally, pyruvate is reduced with NADH to lactate and NAD 1 by lactate dehydrogenase. The oxidation of NADH was monitored photometrically by measuring the absorbance decrease at 340 nm (A 340 ). With the given reaction sequence, cleavage of one molecule cAMP to AMP results in the oxidation of two molecules NADH. The assay was performed in 96-well plates in 200 ml reaction volume. The assay contained 100 mM MOPS-KOH pH 7.5, 15 mM MgCl 2 , 2 mM ATP, 5 mM PEP, 37 U ml 21 myokinase, 16 U ml 21 pyruvate kinase, 22 U ml 21 lactate dehydrogenase, 0.47-0.94 mg ml 21 purified CpdA protein and 0.5 mM NADH. Before the start of the assay, A 340 was monitored in a Tecan Infinite 200 PRO plate reader (Tecan, M€ annedorf, Switzerland) over 3-5 min to ensure that it remained stable. The reaction was started by addition of cAMP (0.25-16 mM) and A 340 was monitored for additional 5-6 min at 308C.
Assay 2. To determine whether CpdA is able to hydrolyze cGMP to GMP, a coupled assay with alkaline phosphatase was performed as described (Kalivoda et al., 2013) with minor modifications. Bovine alkaline phosphatase was added to the reaction mixture to catalyze the release of phosphate from AMP. Solution A consisted of 50 mM MOPS, 50 mM NaCl at pH 7.5. The assay was conducted with 10 mg purified CpdA protein in 800 ml reaction volume and the reaction was started by the addition of cAMP. Samples were taken before and 15, 30, 45, 60 and 180 sec after cAMP addition. The reaction was stopped by addition of 0.1 volumes 55% (wt/vol) trichloroacetic acid and phosphate was detected by measurement of absorption at 820 nm after addition of ammonium molybdate and ascorbic acid as described in the original method.
Assay 3. For the determination of the pH and temperature dependency of CpdA, a PDE assay with the synthetic substrate bis-(p-nitrophenyl) phosphate (bis-pNPP), which is cleaved to p-nitrophenol, was used. Purified CpdA protein was preincubated at the selected temperature (208C-808C) for 5 min in 50 mM MOPS buffer pH 6 with 50 mM NaCl. Bis-pNPP at a final concentration of 3.4 mM was added to start the reaction. Samples were taken at several time points over 10-15 min and A 420 was measured immediately. For the determination of the pH optimum the activity was assayed at 308C between pH 5 to 9 using 50 mM MES (pH 5-7), 50 mM MOPS (pH 6-8) or 50 mM Tris buffer (pH 6.4-9) adjusted to the desired pH. The specific activity with bis-(p-nitrophenyl) phosphate was 0.043 mmol min 21 mg
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at a substrate concentration of 3.4 mM at 308C and pH 6.0.
Analysis of global gene expression using DNA microarrays
Cultures of C. glutamicum WT/pEKEx2, DcpdA/pEKEx2 and WT/pEKEx2-cpdA were precultivated in 50 ml 2xTY medium. 50 ml CGXII main cultures supplemented with 100 mM glucose were inoculated with the precultures to a starting OD 600 of 1. Overexpression of cpdA was induced by addition of 250 mM IPTG. The cells were cultivated until mid-exponential phase (OD 600 of 5) when 25 ml cell culture were harvested by centrifugation (10 min, 4000g, 48C) in ice-filled Falcon tubes and the cell pellets were frozen in liquid nitrogen and stored at 2808C until further processing. The extraction of total RNA, reverse transcription and labelling of the probes as well as the microarray analysis was done as described previously (Vogt et al., 2014) . Genes were considered to be significantly altered, when the mRNA ratio between two samples was 2.0 or 0.5 with a p-value of 0.05 in three biological replicates. The DNA microarray results have been uploaded to the GEO database and are available under series entry GSE81004.
Determination of intracellular cAMP concentrations
C. glutamicum strains were cultivated in CGXII medium with 100 mM glucose to an OD 600 of 5 (mid-exponential phase). Cells of 2 ml culture were harvested by centrifugation, the cell pellet was immediately resuspended in 500 ml 0.1 M HCl and boiled at 958C for 10 min. The samples were then frozen in liquid nitrogen and stored at 2808C until further processing. After thawing, the cells were disrupted by bead beating with a Precellys 24 device (Peqlab Biotechnologie, Erlangen, Germany) and the extract was centrifuged for 15 min, at 16,100g and 48C. The supernatants were neutralized by addition of KOH and the cAMP concentration was measured using the Amersham TM cAMP Biotrak TM EIA kit (GE Healthcare, Frankfurt, Germany) following the manufacturer's instructions. The supernatant samples were measured without dilution. The protein concentration of the supernatants was determined as described above with the bicinchoninic acid assay. Three biological replicates were performed.
